Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
Alkermes' Novel Schizophrenia Drug Shows Less Weight Gain, Addressing Top Patient Complaint
May 22nd 2019Studies presented in posters at the 175th Annual Meeting of the American Psychiatric Association demonstrated that the combination of olanzapine and samidorphan kept weight gain below levels typically seen in commonly used antipsychotics.
Poll Finds Most Workers Can Get Mental Health Care, but a Third Worry About Seeking It
May 21st 2019The poll by the American Psychiatric Association found that young men were especially reluctant to seek mental health care from their employers, even though most workers, especially young ones, said they felt willing to discuss mental health in the workplace.
Hochschild Gives Psychiatrists a View of Bridging the Political Chasm
May 20th 2019A discussion with University of California at Berkeley sociologist Arlie Hochschild, PhD, author of the best-seller Strangers in Their Own Land: Anger and Mourning on the American Right, addressed how social psychiatry can help bridge the current political divide.
Prescription Benefits Consultant Sees Opportunities for Employers in Debate Over Rebates
May 13th 2019As pharmaceutical manufacturers and pharmacy benefit managers point fingers over who is responsible for high drug prices, employers have the opportunity to demand change to business as usual, consultant Chris Robbins of Arxcel says.
Chemo, Then Radiotherapy, May Boost Survival for Patients With Advanced Hodgkin Lymphoma
May 2nd 2019Radiotherapy after chemotherapy is controversial, as evidenced by the fact that doctors for some patients in the study did not follow the protocol for those assigned to radiotherapy and may have affected the results.
Few At-Risk Adults Are Being Referred to Diabetes Prevention Programs, Study Finds
April 27th 2019The CDC created the National Diabetes Prevention Program following a study of a lifestyle intervention; new results show that more than a third of adults who are referred to a program take part, but only a fraction are referred.
CGM Linked to Low A1C Among Blog Readers With Type 1 Diabetes
April 24th 2019The study by researchers at Penn State College of Medicine found those with type 1 diabetes who read blogs had lower glycated hemoglobin (A1C) levels, and the combination of reading blogs and using continuous glucose monitoring produced the best glycemic control.